Fierce Drug Dev Forum 2019 has ended
avatar for Kia Motesharei, Ph.D.

Kia Motesharei, Ph.D.

Former Vice President, Global Head of Business Development, Neurology and Immunology
Kia Motesharei most recently has been Vice President, Global Head Licensing & Business Development, Neurology & Immunology at EMD Serono (Merck outside the US and Canada).  He was a member of Franchise Leadership Team and is responsible for all partnering and licensing transactions within the Neurology & Immunology Franchise at Merck KGaA.  Prior to EMD Serono, Kia was Vice President of Business Development & Alliance Management at Dyax, a biopharmaceutical company specializing in rare disease.  Previously, Kia managed the US operation of Genfit - a French biotech company – in Cambridge and led its global business development as the company’s Chief Business Officer.   Prior to Genfit and over the past 20 years, he has worked for multiple private and public biotech companies with increasing levels of responsibility in R&D, New Technologies, Technical Marketing, Product Management, Business Development and Alliance Management.  

Kia has a successful track record of transactions which include strategic alliances, product and technology licensing, distribution, divestitures, and M&A agreements with major pharmaceutical and biotechnology companies in the US, Europe, Japan, China, LATAM, and Middle East. In addition, he has been involved in a number of financing activities.

Kia received his B.A. in Chemistry from The Colorado College and his Ph.D. in Organic Chemistry from University of California, Los Angles. He completed his postdoctoral training at The Scripps Research Institute as an NIH Fellow.